FFRangio
Angiographic Coronary Vascular Physiologic Simulation Software. 510(k) K192442, from Cathworks, Ltd. (Kfar-Saba, IL). Product code QEK, class 2.
As of Nov 20, 2026, K192442 is an FDA 510(k) held by Cathworks, Ltd., substantially equivalent on Dec 9, 2019 after 94 days, with no recalls tied to it in FDA's recall database.
- Review time: 94 days
- Recalls: 0
CathWorks FFRangioâ„¢ is a software device for the clinical quantitative and qualitative analysis of previously acquired angiography DICOM data for patients with coronary artery disease. It provides FFRangioâ„¢, a mathematically derived quantity, computed from simulated blood flow information obtained from a 3D computer model, generated from coronary angiography images.
- FFRangio SystemK182149 · Cathworks, Ltd. · Dec 19, 2018
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Japan approved CathWorks FFRangio, the same brandPMDA · Dec 10, 2019
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 6, 2019
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1415
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files